Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Invested Capital (2016 - 2022)

Historic Invested Capital for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $123.8 million.

  • Avadel Pharmaceuticals' Invested Capital fell 4864.28% to $123.8 million in Q3 2022 from the same period last year, while for Dec 2022 it was $726000.0, marking a year-over-year decrease of 9967.1%. This contributed to the annual value of $220.6 million for FY2021, which is 2404.16% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Invested Capital of $123.8 million as of Q3 2022, which was down 4864.28% from $131.0 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Invested Capital high stood at $307.0 million for Q2 2020, and its period low was $89.7 million during Q2 2018.
  • In the last 5 years, Avadel Pharmaceuticals' Invested Capital had a median value of $180.2 million in 2018 and averaged $183.4 million.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Invested Capital soared by 228243.23% in 2018 and then plummeted by 4974.83% in 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Invested Capital (Quarter) stood at $118.6 million in 2018, then fell by 22.03% to $92.5 million in 2019, then surged by 214.07% to $290.5 million in 2020, then dropped by 24.04% to $220.6 million in 2021, then plummeted by 43.89% to $123.8 million in 2022.
  • Its Invested Capital was $123.8 million in Q3 2022, compared to $131.0 million in Q2 2022 and $197.9 million in Q1 2022.